RxDoctor Payments Data

Kayode Gbeleye

Psychiatric/Mental Health · Baltimore, MDNPI 1700575123

Payments from drug & device makers

$1,476in general payments, 2019–2025

Across 61 payments — averaging $24.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$294
  • E.r. Squibb & Sons, L.L.C.$205
  • Johnson & Johnson$166
  • Alkermes, Inc.$154
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$131
  • Neurocrine Biosciences, Inc.$129
  • plus $396 from 7 others

What the payments were for

  • Food & beverage$1,476100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,476 in reported general payments places this provider in the 80th percentile of 1,461 psychiatric/mental health providers in Maryland.

See all psychiatric/mental health providers in Maryland

Medicare billing

Part B allowed, 2024
$85,456
Medicare patients
153
Services billed
885

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl26$36,072
Invega SustennaPaliperidone Palmitate11$31,448
RexultiBrexpiprazole11$15,219
TrintellixVortioxetine Hydrobromide37$15,135
Aripiprazole56$6,158
Clozapine48$3,665
Olanzapine-Fluoxetine HclOlanzapine/Fluoxetine Hcl12$1,794
Olanzapine71$1,505
Trazodone Hcl106$1,442
Quetiapine Fumarate90$1,040
Divalproex Sodium ErDivalproex Sodium40$1,026
Divalproex Sodium54$993
Benztropine Mesylate128$941
Haloperidol35$871
Risperidone84$589

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$17$36,07226 claims
Johnson & JohnsonInvega Sustenna$166$31,44811 claims
Otsuka America Pharmaceutical, Inc.Rexulti$118$15,21911 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$18$15,13537 claims
Teva Pharmaceuticals USA, Inc.Loxapine$294$33411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,461 psychiatric/mental health providers in Maryland.

Other psychiatric/mental health in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →